• Z-VAD-FMK: Advancing Apoptosis and Ferroptosis Research w...

  2025-09-29

  Explore how Z-VAD-FMK, a leading cell-permeable pan-caspase inhibitor, enables next-generation insights into apoptosis and ferroptosis signaling. This article uniquely connects mechanistic caspase inhibition with emerging cancer and neurodegenerative disease research.

• AG-490 (Tyrphostin B42): Next-Gen Insights into JAK2/EGFR...

  2025-09-28

  Explore the advanced molecular applications of AG-490, a potent tyrosine kinase inhibitor, in dissecting the JAK-STAT and MAPK signaling pathways for cancer research. This article offers a unique, mechanistic focus on exosomal RNA-driven immunomodulation and innovative uses in signal transduction research.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Unveiling New F...

  2025-09-27

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride, a potent NHE1 inhibitor, advances understanding of Na+/H+ exchanger signaling in cardiovascular and endothelial injury models. This article offers a unique analysis connecting molecular mechanisms with translational potential in sepsis and cardiac research.

• Rucaparib (AG-014699): Unveiling PARP1 Inhibition’s Syste...

  2025-09-26

  Explore how Rucaparib (AG-014699) redefines PARP1 inhibition in cancer biology research, with new insights into DNA damage signaling, mitochondrial apoptosis, and regulated cell death. This article delivers a unique systems-level perspective and integrates the latest mechanistic findings for advanced DNA damage response research.

• A 83-01: Transforming TGF-β Pathway Inhibition for Human ...

  2025-09-25

  Explore how A 83-01, a potent ALK-5 inhibitor, is redefining selective TGF-β pathway inhibition for advanced organoid pharmacokinetic modeling. This in-depth analysis uniquely bridges molecular action, technical applications, and translational insights for next-generation cellular growth inhibition studies.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition in Cancer ...

  2025-09-24

  Discover how BGJ398, a selective FGFR1/2/3 inhibitor, advances oncology and developmental biology research. This article explores novel applications, mechanistic insights, and the interplay between FGFR signaling and tissue morphogenesis.

• (S)-Mephenytoin as a Benchmark CYP2C19 Substrate in hiPSC...

  2025-09-23

  Explore the utility of (S)-Mephenytoin as a cytochrome P450 metabolism probe for in vitro pharmacokinetic studies, with a focus on its application in hiPSC-derived intestinal organoid systems. This article discusses its role as a CYP2C19 substrate and highlights methodological advances in modeling human drug metabolism.

• Clozapine N-oxide: Chemogenetic Dissection of Anxiety Cir...

  2025-09-22

  Explore how Clozapine N-oxide (CNO), a key DREADDs activator and metabolite of clozapine, enables precise modulation of neuronal activity for chemogenetic studies of anxiety and GPCR signaling. This article highlights advanced applications

• Cy3-UTP: A Photostable Fluorescent RNA Labeling Tool for ...

  2025-09-19

  Explore the advanced applications of Cy3-UTP, a photostable fluorescent RNA labeling reagent, in investigating RNA trafficking and interactions within cells. This article highlights how Cy3-modified uridine triphosphate enables rigorous, high-resolution analysis of RNA biology in contemporary research.

• TAK-242 as a Selective TLR4 Inhibitor for Microglia Polar...

  2025-09-18

  This article examines TAK-242 (Resatorvid), a selective TLR4 inhibitor, focusing on its mechanistic role in modulating microglia polarization and suppressing LPS-induced inflammatory cytokine production in neuroinflammation research. Recent findings on the TLR4/NF-κB pathway in ischemic stroke models are discussed.

• br Conflicts of interest br Acknowledgements This

  2025-03-03

  

  Conflicts of interest Acknowledgements This work was sponsored by grants from Longyan University Scientific Research Fund for the Young Scholars (LQ2016010), Middle-aged and Young Teachers Education Research Projects of Fujian Province (JAT170569), Longyan University Scientific Research Fund f

• br Conclusions br Conflict of interest br Introduction Plant

  2025-03-03

  

  Conclusions Conflict of interest Introduction Plants often encounter a series of abiotic stresses during the growth process, including high salinity, extreme temperatures and drought (Knight and Knight, 2001). Plants can adapt through ionic and osmotic homeostasis or osmotic adjustment, con

• br Liver specific AHR deficiency and energy

  2025-03-03

  

  Liver-specific AHR deficiency and energy balance In contrast to the amelioration of hepatic steatosis by global AHR deficiency, targeted knockout of Ahr in hepatocytes exacerbated it in B6 mice fed on a high-fat diet, without interfering with body weight gain [21]. This appeared to result from au

• The enzyme plays an important

  2025-03-03

  

  The enzyme plays an important role in the purine metabolism of this parasite. Like other parasitic protozoa, T. gondii is incapable of de novo purine biosynthesis and depends totally on preformed purines salvaged from the host corticosterone mg for its purine requirements and survival (Perrotto et

• To understand the kinase selectivity profile

  2025-03-03

  

  To understand the kinase selectivity profile of this series, is tamoxifen a chemo , as a representative analog from this series, was profiled against 216 purified protein kinases representing the tyrosine and serine/threonine kinase families using an in-house Caliper EZ Reader mobility shift assay.

15301 records 1/1021 page Next 12345 下5页 Last page